|
US8198270B2
(en)
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
JP5616569B2
(ja)
|
2004-04-15 |
2014-10-29 |
オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
酵素阻害のための化合物
|
|
BRPI0510802A
(pt)
|
2004-05-10 |
2007-11-06 |
Proteolix Inc |
compostos para inibição de enzima
|
|
US8945558B2
(en)
|
2005-10-21 |
2015-02-03 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for treating myocardial infarction comprising administering an IL-6 inhibitor
|
|
JP5436860B2
(ja)
|
2005-11-09 |
2014-03-05 |
オニキス セラピューティクス， インク． |
酵素阻害のための化合物
|
|
AR057582A1
(es)
*
|
2005-11-15 |
2007-12-05 |
Nat Hospital Organization |
Agentes para suprimir la induccion de linfocitos t citotoxicos
|
|
EP3135298B1
(en)
*
|
2006-01-27 |
2018-06-06 |
Keio University |
Therapeutic agents for diseases involving choroidal neovascularization
|
|
EP2025346B1
(en)
|
2006-04-07 |
2016-08-10 |
Osaka University |
Muscle regeneration promoter
|
|
NZ573759A
(en)
|
2006-06-19 |
2012-03-30 |
Proteolix Inc |
Peptide epoxyketones for proteasome inhibition
|
|
KR101508019B1
(ko)
|
2007-01-23 |
2015-04-06 |
고쿠리츠 다이가쿠 호우징 신슈 다이가쿠 |
만성 거부반응 억제제
|
|
EP3246045B1
(en)
*
|
2007-07-26 |
2025-09-03 |
Osaka University |
Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
|
|
EA018973B1
(ru)
|
2007-10-04 |
2013-12-30 |
Оникс Терапьютикс, Инк. |
Кристаллические пептидные кето-эпоксидные ингибиторы протеаз и синтез кето-эпоксидов аминокислот
|
|
TWI528973B
(zh)
|
2008-06-05 |
2016-04-11 |
Chugai Pharmaceutical Co Ltd |
Nerve infiltration inhibitor
|
|
EP2344165A4
(en)
*
|
2008-10-01 |
2012-12-05 |
Reddys Lab Ltd Dr |
PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
|
|
BRPI0919668A2
(pt)
|
2008-10-21 |
2018-05-29 |
Onyx Therapeutics, Inc. |
terapia de combinação com epóxi-cetonas de peptídeo
|
|
KR20160091440A
(ko)
*
|
2008-11-13 |
2016-08-02 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
AR075899A1
(es)
|
2009-03-20 |
2011-05-04 |
Onyx Therapeutics Inc |
Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
|
|
EP2464666B1
(en)
|
2009-07-15 |
2018-03-21 |
Eva Kovacs-Benke |
Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
|
|
TW201600110A
(zh)
*
|
2009-07-31 |
2016-01-01 |
Shin Maeda |
癌之轉移抑制劑
|
|
US8323883B1
(en)
|
2009-10-09 |
2012-12-04 |
Cold Spring Harbor Laboratory |
Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors
|
|
US7947653B1
(en)
|
2009-10-09 |
2011-05-24 |
Cold Spring Harbor Laboratory |
Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers
|
|
EP2498793B1
(en)
*
|
2009-11-13 |
2019-07-10 |
Onyx Therapeutics, Inc. |
Oprozomib for use in metastasis suppression
|
|
PH12012501719A1
(en)
|
2010-03-01 |
2012-11-12 |
Onyx Therapeutics Inc |
Compounds for immunoproteasome inhibition
|
|
SI2578231T1
(sl)
|
2010-05-28 |
2023-01-31 |
Chugai Seiyaku Kabushiki Kaisha |
Okrepljen protitumorski T celični odzivnik
|
|
US20140294854A1
(en)
*
|
2011-03-10 |
2014-10-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Target directed to adipocytes, methods and assays for treatment of obesity
|
|
WO2013175276A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Argen-X B.V |
Il-6 binding molecules
|
|
US9309283B2
(en)
|
2012-07-09 |
2016-04-12 |
Onyx Therapeutics, Inc. |
Prodrugs of peptide epoxy ketone protease inhibitors
|
|
KR101643041B1
(ko)
*
|
2014-04-25 |
2016-07-28 |
아주대학교산학협력단 |
프로테아좀 저해제 및 디히드로피리딘계 화합물을 유효성분으로 함유하는 암의 예방 또는 치료용 조성물
|
|
CN104922659B
(zh)
*
|
2015-07-03 |
2018-04-20 |
刘永庆 |
防治肿瘤和/或慢性结核病的Th2免疫反应抑制剂及其应用
|
|
US20190046497A1
(en)
*
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
|
US11851486B2
(en)
|
2017-05-02 |
2023-12-26 |
National Center Of Neurology And Psychiatry |
Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
|
|
US20200246488A1
(en)
*
|
2017-07-17 |
2020-08-06 |
The Broad Institute, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
|
US11692037B2
(en)
|
2017-10-20 |
2023-07-04 |
Hyogo College Of Medicine |
Anti-IL-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
|
|
WO2019151418A1
(ja)
|
2018-01-31 |
2019-08-08 |
元一 加藤 |
Ｉｌ－６阻害剤を含有する喘息の治療剤
|
|
US20200165608A1
(en)
*
|
2018-11-23 |
2020-05-28 |
Florida State University Research Foundation, Inc. |
Inhibition of vascular endothelial cell-mediated phagocytic processes for treatment of demyelinating conditions
|
|
WO2020213665A1
(ja)
|
2019-04-17 |
2020-10-22 |
国立大学法人広島大学 |
Ｉｌ－６阻害剤及びｃｃｒ２阻害剤を組み合わせて投与することを特徴とする泌尿器がんの治療剤
|